Viatris VTRS
NASDAQ VTRS
$16.51 -0.10 (-0.60%)
As of: Sep 9, 2026 · 2:29 PM EDT

Viatris (VTRS) Other financing activities (2020 - 2026)

Viatris (VTRS) posted Other financing activities of -$24.5 million for Q2 2026, down 8066.67% on a QoQ basis from -$300000.0 in Q1 2026, and up 46.04% year-over-year from -$16.8 million in Q2 2025.

Analysis

Viatris (VTRS) Other financing activities (2020 - 2026) Analysis & Trends

Viatris has reported Other financing activities for 7 years, with the latest figure at -$24.5 million in Q2 2026.

  • On a quarterly basis, Other financing activities rose 46.04% year-over-year to -$24.5 million in Q2 2026; TTM through Jun 2026 was -$59.9 million, a 625.44% decrease from a year earlier, with the FY2025 full-year figure at -$190.1 million, down 164.4% from the prior year.
  • Other financing activities was -$24.5 million for Q2 2026 at Viatris, down from -$300000.0 in the prior quarter.
  • The five-year high for Other financing activities was $122.6 million in Q2 2024, with the low at -$277.2 million in Q4 2023.
  • Average Other financing activities over 5 years is -$4.1 million, with a median of $650000.0 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Other financing activities jumped 23666.67% in 2023, then sank 1867.74% in 2025.
  • Over 5 years, Other financing activities stood at $17.0 million in 2022, then slumped by 1730.59% to -$277.2 million in 2023, then soared by 135.46% to $98.3 million in 2024, then tumbled by 112.21% to -$12.0 million in 2025, then sank by 104.17% to -$24.5 million in 2026.
  • The last three Other financing activities figures came in at -$24.5 million (Q2 2026), -$300000.0 (Q1 2026), and -$12.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.57 Bn 38.91 Bn 2.15 Bn
2 Viatris 19.20 Bn 18.31 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 520.75 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn
9 Fennec Pharmaceuticals 406.25 Mn 365.00 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.50 Mn
Mar 31, 2026 -300,000.00
Dec 31, 2025 -12.00 Mn
Sep 30, 2025 -23.10 Mn
Jun 30, 2025 -45.40 Mn
Mar 31, 2025 -109.60 Mn
Dec 31, 2024 98.30 Mn
Sep 30, 2024 68.10 Mn
Jun 30, 2024 122.60 Mn
Mar 31, 2024 6.20 Mn
Dec 31, 2023 -277.20 Mn
Sep 30, 2023 71.30 Mn
Jun 30, 2023 21.10 Mn
Mar 31, 2023 11.80 Mn
Dec 31, 2022 17.00 Mn
Sep 30, 2022 300,000.00
Jun 30, 2022 900,000.00
Mar 31, 2022 400,000.00
Dec 31, 2021 500,000.00
Sep 30, 2021 9.60 Mn